Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU
Background5-Fluorouracil (5-FU) is one of the most common chemotherapy drugs used to treat colorectal cancer (CRC), which often develops resistance in more than 15% of patients. Curcumin, an active component of Curcuma longa, has been reported to show antitumor activity in CRC and, furthermore, enha...
Main Authors: | Jingbo Yang, Chengyan He, Ning Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.1032256/full |
Similar Items
-
Curcumin Enhances the Efficacy of 5-FU in Colo205 Cell Lines
by: Ebru Öztürk, et al.
Published: (2017-11-01) -
Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy
by: Nair Hariprasad Haritha, et al.
Published: (2021-07-01) -
New Hybrid Scaffolds Based on 5-FU/Curcumin: Synthesis, Cytotoxic, Antiproliferative and Pro-Apoptotic Effect
by: Gustavo Moreno-Quintero, et al.
Published: (2023-04-01) -
Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy
by: Nair Hariprasad Haritha, et al.
Published: (2023-12-01) -
Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment
by: Aranka Brockmueller, et al.
Published: (2023-03-01)